4883 — Modalis Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 3,857 | 5,421 | 4,936 | 2,933 | 1,883 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6.6 | — | — | — | — |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,875 | 5,449 | 5,067 | 3,061 | 1,956 |
Net Property, Plant And Equipment | 49 | 49.8 | 224 | — | — |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 3,938 | 6,277 | 6,069 | 3,130 | 2,026 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 91.1 | 58.3 | 181 | 142 | 198 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 95.9 | 70.2 | 520 | 189 | 646 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 3,843 | 6,207 | 5,549 | 2,941 | 1,380 |
Total Liabilities & Shareholders' Equity | 3,938 | 6,277 | 6,069 | 3,130 | 2,026 |
Total Common Shares Outstanding |